Pleased with today's presentation, except the reference to the possibility of using the IP as collateral for debt financing. IMHO, that could result in current ownership becoming totally vulnerable to a creditor should a default occur. More dilution, while unpleasant, would not be cataclysmic, but falling into the control of a creditor could wipe out SH equity.
Other than the above concern, I really think we are positioned very well for tremendous appreciation of our Cytodyn investment.